Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery
BJU International, 11/09/09
Masumori N et al. – The symptomatic improvement provided by TURP lasts for >10 years, although there is a gradual deterioration with time. The QoL index remained improved for 12 years regardless of the preoperative urodynamic findings.
Related Articles
Systematic Review and Meta-analysis of Transurethral Resection of the Prostate Versus Minimally Invasive Procedures for the Treatment of Benign Prostatic Obstruction
Urology, 11/04/09
Relevance Score: 79%
Resistive Index: A Newly Identified Predictor of Outcome of Transurethral Prostatectomy in Patients With Benign Prostatic Hyperplasia
Urology, 11/12/09
Relevance Score: 68%
Differences in Initial Benign Prostatic Hyperplasia Management Between Primary Care Physicians and Urologists
The Journal of Urology, 11/02/09
Relevance Score: 67%
Stone Formation in Prostatic Urethra After Potassium-Titanyl-Phosphate Laser Ablation of the Prostate for Benign Prostatic Hyperplasia
Journal of Endourology, 10/13/09
Relevance Score: 67%
Etiopathogenesis of benign prostatic hypeprlasia
Indian Journal of Urology, 10/13/09
Relevance Score: 65%
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antimuscarinics in men with lower urinary tract symptoms suggestive of bladder outlet obstruction due to benign prostatic hyperplasia
Current Opinion in Urology, 12/11/09
The current status of robot-assisted laparoscopic prostatectomy
Current Opinion in Urology, 12/11/09
Phosphodiesterase-5 inhibitors and benign prostatic hyperplasia
Current Opinion in Urology, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


